The explicit use of race in medical decision making is contested. Researchers have hypothesized that physicians use race in care when they are uncertain.
T he appropriate use of race in medical decision making remains contested, in part because of disagreement over the clinical utility of race. [1] [2] [3] [4] Some believe that ignoring race is detrimental to understanding differences in risk-factor profiles, disease prevalence, and severity. They contend that race correlates with a person's genetic ancestry, which may facilitate testing, diagnosis, and treatment. 5 Others do not view race as a useful categorization of genetic or biological information about the response to drugs, diagnosis, or causes of disease. 6 Some researchers contend that racial group health differences are not based upon biological or genetic differences but that members of racial minority groups may develop worse health from recurrent encounters with racism that lead to greater activation of the physiological stress response. 7, 8 Others have more recently suggested that racism can lead to epigenetic changes, which may be passed down across generations. 9 Given the diversity of perspectives, researchers have begun to investigate how physicians use race in their medical decision making. 10 When probed, physicians express uncertainty about how and whether race should be used in medical decision making. 11, 12 Some clinical guidelines make recommendations by race (eg, hypertension treatment) [13] [14] [15] ; however, recommendations regarding race often vary across guidelines for the same condition (eg, prostate and colorectal cancer screening guidelines [14] [15] [16] [17] ). In addition, race is often factored into the results of medical tests (eg, glomerular filtration rate, lung function). Studies have found that providers frequently employ race in their decision making, even in the midst of ambiguity regarding what race measures. 18 Uncertainty is common in medicine. It may be due to ambiguous patient presentations, multiple diagnoses and treatment possibilities, variation in treatment efficacy across individuals, and poor communication between doctors and patients. [19] [20] [21] Some of these scenarios are more common when physicians treat patients whose backgrounds differ from their own background. Individuals from different cultural backgrounds may convey and interpret symptoms differently. In addition, there is considerable evidence that racial and ethnic minorities experience poorer communication with physicians than white patients, particularly in racially discordant doctorpatient relationships. [22] [23] [24] [25] Patients from minority groups may be less likely to trust physicians and confide in them, [26] [27] [28] and studies show that among socially marginalized patients physicians have lower levels of trust in minorities than in whites. 29 Anxiety due to uncertainty (ADU) is associated with physician characteristics, such as gender, clinical experience, and specialty. 30, 31 It also affects physician behaviors, such as test ordering. 32, 33 Cognitive psychology suggests that stress, anxiety, and uncertainty activate implicit biases and stereotyping. 34, 35 Uncertainty may also be associated with explicit or deliberate use of race. For example, in the face of an uncertain patient presentation, physicians may draw on data collected at the population level and "statistically discriminate," that is, uncritically apply population data to individuals. 36, 37 If physician uncertainty is higher in visits of racial/ethnic minority patients and reactions to uncertainty, such as anxiety, systematically lead to different physician behaviors and choices, 38, 39 we might expect to see different treatment for patients from different racial backgrounds. 21, 40 In this study, we investigated the association between ADU and self-reported use of race in medical decision making. The study is part of the Physicians' Understanding of Human Genetic Variation (PUHGV) study, which examines the relationship between race and genetics in medical decision making (Bonham et al, unpublished data) . We have modified the conceptual model from the parent study ( Fig. 1) to show the hypothesized relationship between physicians' ADU and medical decision making.
METHODS

Study Design and Setting
As part of the PUGHV study, the "Health Professionals Genetics Education Needs Exploration Survey" (HP GENE) was developed through focus groups, cognitive interviews, and pilot testing (Bonham et al, unpublished data) . From April 2010 to December 2010, the HP GENE survey was administered by the web and the mail to a national sample of 2122 clinically active general internists. The sample was drawn from the SK&A AMA Masterfile physician database in 2 batches. First, a general random sample (n = 1929) was selected from the overall database. This was supplemented by a sample of physicians who graduated from historically black medical schools (n = 193) in an effort to increase the representation of black physicians in the overall sample and improve the study's ability to detect differences between black and white physicians. We excluded physicians who were not currently practicing general internists according to their office staff or did not have a current US mail address, and identified a sample size of 1738 eligible physicians. The institutional review boards at the National Human Genome Research Institute, Johns Hopkins University, and Miami University of Ohio approved the survey.
Measurements ADU
Our main predictor variable was ADU. The anxiety due to uncertainty scale quantifies emotional reactions to conditions of clinical practice and has been shown to be highly valid and reliable in similar populations. 30, 31 The 5 items in the scale are: (1) the uncertainty of patient care often troubles me; (2) I find the uncertainty involved in patient care disconcerting; (3) I usually feel anxious when I am not sure of the diagnosis; (4) uncertainty in patient care makes me uneasy; and (5) I am quite comfortable with the uncertainty in patient care. Each item is rated on a 6-point Likert scale from 0 = strongly disagree to 5 = strongly agree. The last item is reverse coded for consistency. The individual items are summed for an overall score with higher scores indicating higher ADU.
Use of Race in Medical Decision Making
Our main outcome variable was use of race in medical decision making. We measured self-reported use of race with the Bonham and Sellers Racial Attributes in Clinical Evaluation (RACE) scale. This scale consists of 7 items which load on a single factor and have high internal consistency (Cronbach's a = 0.86) (Bonham et al, unpublished data). The items are: (1) I consider information from patients about their racial background; (2) I consider my patients' race to better understand their genetic predispositions; (3) I consider my patients' race when making decisions about which medications to prescribe; (4) I consider my patients' race in determining genetic risk for common, complex diseases (eg, kidney disease or diabetes); (5) I consider my patients' race in making medication dosage decisions; (6) I consider my patients' race when determining age of initiation of screening for certain diseases; and (7) I consider my patients' race in determining how aggressively to treat particular diseases. Each item is rated on a 5-point Likert scale, from 0 = none of the time and 4 = all of the time. The 7 items are summed to produce an overall score with higher scores reflecting greater use of race in medical decision making.
Covariates of Interest
The survey collected demographic information (eg, age, race, gender), as well as information about nativity, location of medical school, genetics coursework, fellowship training, years in practice postresidency, current level of clinical work, and the estimated racial composition of each physician's patient panel. Respondents were also asked "What does the term "race" mean to you?" and instructed to choose 1 item that best represents the term from 10 choices: (1) biological group; (2) cultural group; (3) genetic ancestral group; (4) lifestyle/behavioral group; (5) population group; (6) religious group; (7) social identity group; (8) species; (9) none of the above; or (10) other. These responses were grouped into biological group (responses 1 and 8), genetic ancestral group (response 3), sociocultural group (responses 2, 4, 5, 6, and 7), and none of above/other (responses 9 and 10), hereafter referred to as physicians' meaning of race.
Statistical Analysis
We used bivariate linear regression to determine whether physicians' demographic characteristics, practice experience, and meaning of race were associated with ADU. We also used bivariate regression to determine whether physician characteristics, practice experience, and meaning of race were associated with scores on the RACE scale. Finally, we examined the association of ADU with RACE, adjusting for potential confounders (variables associated with either ADU or the RACE scale with P-values <0.10 in unadjusted analyses). For those variables that were collinear (eg, age and years in practice), we included only the variable with the larger unadjusted coefficient in the multivariate regression models. Analyses were performed using the SAS Enterprise Guide, version 5.1.
RESULTS
Among the 1738 eligible physicians, 787 completed the survey for a response rate of 45%. There were no statistically significant differences between respondents and nonrespondents with regard to age or gender. We could not compare the racial composition of responders and nonresponders because the SK&A physician database vendor used graduation from a historically black medical school as a proxy for race, and this method was found to be unreliable. Table 1 shows characteristics of the sample. The mean age of respondents was 49 years. The majority of physicians were male, white, born in the United States, and had graduated from a US medical school. The method used to oversample black physicians was not successful; only 6% of the sample was African American. Although 89% of US medical graduates (USMGs) were born in the United States, only 13% of international medical graduates (IMGs) were born in the United States. Compared with their white colleagues, a higher proportion of physicians from all minority groups were foreign born; they also had significantly fewer years in clinical practice (5-6 y less) and cared for more nonwhite patients (data not shown). Eighty-seven percent of respondents identified their specialty as general internal medicine. This rose to 94% when those who identified themselves as hospitalists were included as generalists. Respondents spent >85% of their time in clinical practice and had patient panels that were predominantly white. Most physicians considered races to be genetic ancestral groups (61.6%). Far fewer physicians thought races were biological groups (20%) or sociocultural groups (16.1%).
The mean score on the ADU scale was 19.9 (SD, 5.6; median, 20.0). The range of ADU was 5-30. In unadjusted analyses (Table 2) , older age and more years in practice were associated with lower ADU; female gender, Asian race, being an IMG, and spending more days per week seeing patients were associated with higher ADU. Being African American (vs. white), having had genetics coursework, fellowship training, and percent of nonwhite patients in physician panels were not associated with ADU. Physicians who understood the term "race" to mean biological or genetic ancestral group did not score differently on ADU from those who understood race to mean a sociocultural group; however, the few physicians who chose none of the response choices or "other" to define race scored significantly lower on ADU.
The mean of the RACE scale was 13.5 (SD 5.6; median 13.0; range, 0-28). In bivariate analyses, ADU was positively associated with the self-reported use of race in medical decision making (B = 0.14, P < 0.001). In addition, black or Asian race, being foreign born, being an IMG, the amount of time seeing patients per week, and having a higher percentage of nonwhite patients in one's panel were positively associated with RACE (P < 0.05). Physicians' definitions of race were also associated with the RACE scale, such that those who understood race to mean biological or genetic ancestral groups used race more than those who understood races to mean sociocultural groups. Fellowship training was marginally associated with RACE (P < 0.10); those who were not fellowship trained reported using race more than those with fellowship training. Age, gender, genetics coursework, and years in practice were not associated with RACE in bivariate analyses (data not shown).
After adjustment for potential confounders (Table 3) , the association between ADU and use of race as measured by the RACE scale remained statistically significant. For every 1-point increase in ADU, the score on the RACE scale increased by 0.08. Variables significantly associated with more self-reported use of race in the multivariate model included being an IMG, not having done a fellowship, and the percent of nonwhite patients in the physician's panel. Understanding the term race to mean a biological or genetic ancestral group rather than a sociocultural group was also associated with greater use of race. The associations between years in medical practice and self-reported use of race was positive and of borderline statistical significance (P = 0.063) in multivariate analyses. Gender, physician race, nativity, and the amount of time seeing patients each week were not associated with RACE after controlling for potential confounders. The overall R 2 for the model was 0.10.
DISCUSSION
To our knowledge, this is the first study to examine the association between physician ADU and use of race in medical decision making. Using data from a national survey, we found that general internists with higher ADU report using race in medical decision making at higher levels than those with lower ADU. We also found that internists who graduated from international medical schools (IMGs), were not fellowship trained, and had more nonwhite patients in *b coefficient gives the change in the RACE score for every 1 unit increase (eg, every additional point in ADU or percent of nonwhite patients) or between the indicated group and reference group (eg, female vs. male).
w Adjusted for anxiety due to uncertainty, gender, race, nativity, location of medical school, fellowship training, years in practice, clinical days per week, percent of nonwhite patients, and understanding of race.
-indicates variables not included in the multivariate model. their panels used race more than their counterparts who were US medical graduates (USMGs), completed a fellowship, and had fewer nonwhite patients, respectively. In addition, physicians who understood race to refer to a biological or genetic ancestral group used race more in decision making than those who understood the term "race" to mean "sociocultural group."
The cognitive psychology literature shows that under conditions of stress, individuals seek to preserve cognitive resources. 34, 35 Physicians' explicit or deliberate use of race may help to preserve cognitive resources under conditions of stress and anxiety. Although we found a relatively small effect of ADU on self-reported use of race, when one considers the number of patients seen by individual physicians over time, the effect of ADU on use of race may be amplified and contribute to differences in care between patient populations.
Because our survey did not collect performance metrics for physicians, we cannot determine whether the explicit use of race had any effect, positive or negative, on clinical outcomes, patient satisfaction, or health care disparities. Use of race in medical decision making may benefit patients, particularly if race can efficiently and reliably convey useful information about a patient's risk or response to treatment. The use of race is similar to the dilemma that physicians face whenever they seek to apply group-level data from research studies to individual patients. Use of race may also benefit patients if racial information can "sensitize" physicians to factors that may be relevant in a patient's care and warrant further investigation. Culturally sensitive providers tend to be knowledgeable about differences between social groups, express humility and a lifelong commitment to self-evaluation, and refrain from assuming that any 1 patient represents a prototypical group member. 41, 42 The authors of the seminal Unequal Treatment report and others have hypothesized that uncertainty may contribute to health care disparities. 21, 43 Although this study cannot test for such associations, it is important to cautiously highlight the potential links between ADU, the explicit use of race, and undesirable outcomes. Many physicians seem to have low levels of explicit bias or prejudice, 34, 44 and few mechanisms, beyond implicit bias, have been identified to explain how physicians may contribute to disparities. Race may be one of the several patient characteristics on which physicians rely when they have more ADU. Studies suggest that family history and perceptions of patients' psychosocial characteristics may be more important than race in physicians' overall decision making. 45, 46 That said, physicians often assess members of minority groups less positively than whites on domains such as intelligence, social support, trustworthiness, and adherence to medical advice. 29, 46, 47 Further research is needed to refine our knowledge of how patient factors influence physician decision making.
In addition to the lack of treatment and health outcome data, this study has several other limitations, including its cross-sectional design and use of self-reported measures that may be subject to social desirability bias. We can neither tell which circumstances create more ADU, nor which disease categories, clinical scenarios, or patient characteristics make physicians more or less prone to use race in medical decision making. Furthermore, the RACE scale did not allow us to identify how physicians consider race (eg, whether they consider it as a marker of self-efficacy, social support, social or environmental exposures, or biological predispositions), or the relative weight that physicians place on race versus other types of information when they are uncertain. Lastly, the response rate to our survey was low (45%) but similar to other studies of physicians. 48, 49 Physicians encounter uncertainty constantly, and this study finds several new associations with ADU. ADU may not be altogether undesirable. A certain amount of ADU may push physicians to explore a broad array of potential diagnostic and treatment options to make good clinical decisions. The medical community is increasingly aware of the relationship between uncertainty, stress, and activation of implicit biases. 34, 37 However, this study demonstrates a new finding-the association between high ADU and greater explicit use of race in medical decision making. Under conditions of stress it is not clear which cognitive shortcut is more likely to be used-implicit beliefs about racial groups or explicit beliefs about the clinical relevance of race. In addition, the implications of both types of cognitive shortcuts for patient care remain largely unknown. Our study leaves questions unanswered; however, the associations we found suggest future research should seek to improve our understanding of physicians' emotional reactions to uncertainty in clinical practice and their reliance on social categories to manage these emotional reactions. To address the main limitation of the current study, we will need research that links ADU to actual decisions (collected through use of clinical vignettes or direct observations of patient care) and patient outcomes for diverse populations. This work will reveal whether associations between ADU and use of race have implications for patient care and health outcomes.
